Usage-driven AI stocks are less exposed to frontier-model companies as the AI trade separates winners from losers. All rose, all will fall, and only some will recover; favor usage-driven over frontier-biased stocks. DigitalOcean is GAAP profitable; its token usage is a nonlinear revenue proxy. SiTime is GAAP profitable; robotics, defense and self-driving are each growing 50% year over year. CrowdStrike and Rubrik also do not rely on frontier models, though valuation is a concern. x.com  x.com 

AI's application layer remains the long-term bet: after 24 months in infrastructure on obvious earnings, capital must now move to the layer that produces durable economic value. Tempus AI's edge is proprietary data, which stays scarce as raw intelligence gets cheaper. Eli Lilly's LillyPod pairs 1,000 Blackwell GPUs with decades of clinical data, an underrated moat. Lemonade's tech yields cost, price and growth edges. Coinbase provides the stablecoin financial guardrails agentic AI needs. x.com 

Tempus AI is a short idea because the stock is being pumped on recent FDA clearances for its EKG-AI tools, while the revenue from them is far off and may never materialize. x.com 

Better underwriting at Root, AI data demand at Innodata, defense breadth at Applied Aerospace & Defense, scaled voice AI at SoundHound, more organ access via TransMedics, profitable insurance at Lemonade, autonomous defense at Ondas and successful medicines at AbCellera could drive outsized growth. These eight smaller companies have a realistic path to 5x+ over 5-10 years if they execute on those opportunities. x.com  x.com  x.com  x.com  x.com  x.com  x.com  x.com 

SiTime is an under-the-radar AI infrastructure winner posting triple-digit growth while likely trading below 40x NTM EPS. Its silicon timing chips replace quartz across data centers, robots, drones, defense and robotaxis. Q3 guidance implies ~250% YoY revenue and ~315% EPS growth; the Renesas deal adds ~$85M, leaving ~30% organic QoQ growth. It sells more into each rack, expects 1.6T optical revenue to double in 2027 with higher share and ASPs, and customers order 12-18 months out. x.com  x.com  … Show more

Tempus AI is a second- or third-tier genomic lab whose AI story is marketing mumbo jumbo, and its management team are promoters. x.com 

Lemonade is light years ahead of competitors in agentic insurance as policies shift from set-and-forget to hundreds of micro-interactions each year. It is the first company to truly enter this model while incumbents still work on AI premium-pricing models. Pet insurance involves frequent small claims, and car telematics keeps updating driving-based prices and safety assessments. x.com 

Tempus AI's thesis remains intact after objectively strong earnings and a guidance raise. It looks less threatened by Anthropic than other software names because its datasets form its moat, for now. Software multiples remain a big question, and these stocks are struggling to catch a break, but the technical setup still looks good despite the pullback. x.com 

Tempus AI's 2025 growth was less impressive than it looks: only half was organic, with the other half coming from the Ambry acquisition. x.com 

AI spending makes Defiance AI Infrastructure the simplest way to own chips, cooling and power. Roundhill Memory alone holds makers for a shortage expected into 2028. VanEck Semiconductor is the broadest chip fund and a core long-term AI holding. Global X Robotics & AI owns factory and hospital automation sellers now. ARK Autonomous Tech covers autonomy but is the most aggressive, volatile pick. Roundhill Neocloud is the list's only rental fund and most direct way to own AI compute demand. x.com  … Show more